The closest safety dataset is the Increlex (mecasermin) clinical program , which followed 71 pediatric patients with severe primary IGFD on twice-daily SubQ rhIGF-1 for a mean of 3.9 years (some patients up to 11.5 years)
BPC-157 research reference BPC-157 with batch, stock, storage, and documentation context
Contains NO artificial color, sugar, salt, wheat, gluten, soy, milk, egg or preservatives
inability to concentrate well
Symptoms that may indicate Candida overgrowth include: Gas, bloating, or irregular digestion Sugar cravings Brain fog or fatigue Skin rashes or recurring flares A history of frequent antibiotic or steroid use Its also worth noting that skin and gut fungal overgrowths can exist together, compounding the problem
Adlakha-Hutcheon G, et al